{"id":280862,"date":"2022-07-27T12:09:25","date_gmt":"2022-07-27T14:09:25","guid":{"rendered":"https:\/\/teknomers.com\/fr\/biontech-et-pfizer-etudient-un-nouveau-vaccin-candidat-devrait-egalement-etre-efficace-contre-lomikron\/"},"modified":"2022-07-27T12:09:26","modified_gmt":"2022-07-27T14:09:26","slug":"biontech-et-pfizer-etudient-un-nouveau-vaccin-candidat-devrait-egalement-etre-efficace-contre-lomikron","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/biontech-et-pfizer-etudient-un-nouveau-vaccin-candidat-devrait-egalement-etre-efficace-contre-lomikron\/","title":{"rendered":"BioNTech et Pfizer \u00e9tudient un nouveau vaccin candidat : \u200b\u200bdevrait \u00e9galement \u00eatre efficace contre l&#8217;omikron"},"content":{"rendered":"\n<p>La soci\u00e9t\u00e9 pharmaceutique allemande BioNTech et son partenaire am\u00e9ricain Pfizer ont lanc\u00e9 une nouvelle \u00e9tude sur l&#8217;efficacit\u00e9 et la s\u00e9curit\u00e9 d&#8217;un candidat vaccin.  Cela fonctionnerait selon la m\u00eame technologie d&#8217;ARNm que le vaccin existant de BioNTech et Pfizer.  Les soci\u00e9t\u00e9s pharmaceutiques l&#8217;ont annonc\u00e9 mercredi.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.hln.be\/medisch\/biontech-en-pfizer-onderzoeken-nieuw-kandidaat-vaccin-moet-ook-werkzaam-zijn-tegen-omikron~a482eb726\/\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-34<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 pharmaceutique allemande BioNTech et son partenaire am\u00e9ricain Pfizer ont lanc\u00e9 une nouvelle \u00e9tude sur l&#8217;efficacit\u00e9 et la s\u00e9curit\u00e9 d&#8217;un candidat vaccin. Cela fonctionnerait selon la m\u00eame technologie d&#8217;ARNm que le vaccin existant de BioNTech et Pfizer. Les soci\u00e9t\u00e9s pharmaceutiques l&#8217;ont annonc\u00e9 mercredi. ttn-fr-34<\/p>\n","protected":false},"author":1,"featured_media":280863,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[22925,8694,841,6321,4322,1909,1643,34922,30499,680,29947,715],"class_list":["post-280862","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-biontech","tag-candidat","tag-contre","tag-devrait","tag-efficace","tag-egalement","tag-etre","tag-etudient","tag-lomikron","tag-nouveau","tag-pfizer","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/280862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=280862"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/280862\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/280863"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=280862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=280862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=280862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}